Related Experiment Videos
CD8+ T-cell immunity to HIV infection
Paolo Piazza1, Zheng Fan, Charles R Rinaldo
1Department of Infectious Diseases and Microbiology, University of Pittsburgh Graduate School of Public Health, 425 Parran Hall, Pittsburgh, PA 15261, USA. paolo@pitt.edu
Clinics in Laboratory Medicine
|September 25, 2002
Summary
HIV-1-specific CD8+ T cells are crucial for controlling HIV-1 infection. New immunotherapies and vaccines aim to restore or enhance T-cell immunity to combat HIV-1, despite challenges from viral diversity and immune defects.
Area of Science:
- Immunology
- Virology
- Cellular Immunity
Background:
- HIV-1-specific CD8+ T cells play a vital role in controlling HIV-1 infection.
- Research has significantly advanced understanding of cellular immunity through HIV-1 studies.
- Mechanisms of CD8+ T-cell control loss include intrinsic defects and viral escape.
Purpose of the Study:
- To review the importance of CD8+ T cells in HIV-1 control.
- To discuss mechanisms leading to loss of T-cell control.
- To explore current and future strategies for immunotherapy and vaccine development.
Main Methods:
- Review of existing scientific literature on HIV-1 immunology.
- Analysis of T-cell responses and their mechanisms in HIV-1 infection.
- Evaluation of therapeutic and prophylactic approaches.
Main Results:
- Combination antiretroviral therapy controls HIV-1 but doesn't fully restore T-cell immunity in chronic infection.
- Early HIV-1 infection treatment can maintain T-cell reactivity.
- Promising immunotherapies include in vivo virus activation and ex vivo engineered dendritic cells.
- Cytokines and chemokines show potential for augmenting T-cell responses.
- New vaccine candidates show promise in inducing T-cell responses.
Conclusions:
- Despite advances, complete control of HIV-1 infection remains a goal.
- Enhancing T-cell repertoire and function is key for immunotherapy.
- Next-generation vaccines are improving T-cell induction for prevention.